FDA Flu Vaccine Immunization Program
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Points of contact
-
- tbd@fda.gov
- Joshua Holliday joshua.holliday@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Department of Health and Human Services Food and Drug Administration is forecasting a new contract for flu vaccine immunization, targeting vaccine production for two distinct age groups. The solicitation is estimated to be released on July 1, 2026, with an anticipated contract award date of September 1, 2026, focusing on the Pharmaceutical Preparation Manufacturing sector (NAICS 325412). The procurement involves producing 4,100 total vaccine units: 4,000 units formulated for adults under 65 years and 100 units specifically designed for adults 65 years and older.
The contract does not have a specific set-aside classification and appears to be open to competitive bidding for pharmaceutical manufacturers. Primary points of contact include Joshua Holliday (joshua.holliday@fda.hhs.gov) from the FDA, who can provide additional details about the opportunity. While specific budget ranges are not disclosed in the forecast, interested manufacturers in the pharmaceutical preparation sector should prepare comprehensive proposals that demonstrate capability to produce age-specific flu vaccine formulations by the estimated award date in September 2026.
Forecast text
This order will consist of a. 4,000 units formulated for adults under 65 years of age and 100 units formulated specifically for adults 65 years of age and older.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast